News Search Results
Jul 31, 2024, 17:20 ET Biobanking Market size is set to grow by USD 1.66 billion from 2024-2028, Growing demand for personalized medicine boost the market, Technavio
trend towards emergence of stem cells storage in biobanks. However, increasing ethical issues poses a challenge. Key market players include AMS Biotechnology Europe Ltd., ASKION GmbH, Azenta Inc., Bay Biosciences LLC, BioIVT LLC, Boca Biolistics LLC, CTIBiotech, Cureline Inc., Danaher Corp., Firalis SA,
More news about: Technavio
Jul 31, 2024, 17:15 ET In-Vitro Diagnostics Instruments Market size is set to grow by USD 52.9 billion from 2024-2028, Growing geriatric population boost the market, Technavio
sector, handling various samples like blood, serum, plasma, urine, saliva, and tissues. Blood banks, home care settings, pharmaceutical companies, biotechnology firms, academic institutes, and non-communicable disease segments are key end-users. Infectious diseases and chronic conditions including cardiology,
More news about: Technavio
Jul 31, 2024, 17:10 ET Scientific Instrument Market size is set to grow by USD 19.96 billion from 2024-2028, Increasing investments in drug discovery boost the market, Technavio
equipment are in high demand. Handheld and portable instruments are popular for field research in healthcare companies, retail sales, and online sales. Biotechnology, materials science, environmental science, private organizations, and academic institutions are major buyers. Electron microscopes, mass spectrometers,
More news about: Technavio
Jul 31, 2024, 16:16 ET Corteva Reports Second Quarter and First Half 2024 Results, Updates Full-Year Guidance
commercialize Corteva's pipeline; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of Corteva's biotechnology and other agricultural products; (iv) effect of changes in agricultural and related policies of governments and international organizations; (v)
More news about: Corteva, Inc.
Jul 31, 2024, 12:50 ET Bühler and NRGene Canada open North American Insect Center
companies who are choosing to invest and grow their business in our province," Harrison noted. "Our reputation as global leaders in agricultural and biotechnology is attracting record capital investment into the province. We're very proud to see the North American Insect Center join a growing list of cutting-edge
More news about: NRGene
Jul 31, 2024, 12:50 ET Bühler and NRGene Canada open North American Insect Center
companies who are choosing to invest and grow their business in our province," Harrison noted. "Our reputation as global leaders in agricultural and biotechnology is attracting record capital investment into the province. We're very proud to see the North American Insect Center join a growing list of cutting-edge
More news about: NRGene
Jul 31, 2024, 10:01 ET Egg Powder Market is Projected to Grow with a CAGR of 9.6% During Forecast Period by 2034 | Future Market Insights Inc.
to food ingredients, nutrition & health solutions, animal nutrition, and marine nutrients. She is also well-versed in the pharmaceuticals, biotechnology, retail, and chemical sectors, where she advises market participants to develop methodologies and strategies that deliver results. Her
More news about: Future Market Insights
Jul 31, 2024, 09:00 ET Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen
July 31, 2024 /PRNewswire/ -- Alcyone Therapeutics Inc. (Alcyone), a clinical-stage biotechnology company pioneering next-generation precision genetic therapies and precision delivery solutions of therapies for complex neurological conditions,
More news about: Alcyone Therapeutics
Jul 31, 2024, 08:00 ET Halia Therapeutics and Biolexis Therapeutics' Partnership Successfully Identifies Novel Clinical Candidate Targeting NLRP3-Driven Neuroinflammation
biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, and Biolexis Therapeutics, a biotechnology company specializing in AI-enabled drug discovery, today announced an ongoing collaboration that successfully identified a novel brain-penetrant
More news about: Halia Therapeutics
Jul 31, 2024, 08:00 ET TCBP Announces Plan to Implement ADS Ratio Change
July 31, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it will change its ratio
More news about: TC BioPharm
Jul 31, 2024, 07:00 ET ELIAS Animal Health to Conduct Limb-Sparing Canine Osteosarcoma Clinical Study with Grant from Morris Animal Foundation
https://www.morrisanimalfoundation.org/article/new-study-aims-revolutionize-osteosarcoma-treatment-giant-dog-breeds About ELIAS Animal HealthELIAS Animal Health is a medical biotechnology company advancing novel targeted T cell-based and oncolytic immunotherapies for the treatment of canine cancers. The ELIAS Cancer Immunotherapy
More news about: ELIAS Animal Health
Jul 31, 2024, 06:00 ET IDEAYA Biosciences Announces Option and License Agreement for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program with Biocytogen
which represents an emerging class of precision medicine targets. About BiocytogenBiocytogen (HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology,
More news about: IDEAYA Biosciences, Inc.
Jul 30, 2024, 17:55 ET 3D Printing Medical Devices Market size is set to grow by USD 7.07 billion from 2024-2028, Increased demand for personalized or customized medical devices boost the market, Technavio
printed bone features a micropore surface that allows osteocytes to adhere, join, and heal better than traditional metal implants. ORGANOVO, a biotechnology company, is pioneering the use of 3D bioprinting to develop in vivo liver tissues for treating rare, life-threatening diseases. Their product, the
More news about: Infiniti Research, Inc.
Jul 30, 2024, 17:50 ET Synthetic Biology Market size is set to grow by USD 55.60 BILLIOn from 2024-2028, growing applications leading to growing adoption of synthetic biology boost the market, Technavio
Script, and Genome editing companies. PCR and Real-time PCR assays are essential tools. The market is vast, with potential in pharmaceuticals, biotechnology, and fuel alternatives. Discover 360° analysis of this market. For complete information, schedule your consultation -
More news about: Technavio
Jul 30, 2024, 17:20 ET Atomic Spectroscopy Market size is set to grow by USD 2.46 billion from 2024-2028, Increased funding by government organizations for environmental testing and product safety to boost the market growth, Technavio
Technology (Atomic absorption, X ray fluorescence, X ray diffraction, and ICP-MS and others), End-user (Pharmaceutical and biotechnology testing, Food and beverage testing, Environmental testing, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW))
More news about: Technavio
Jul 30, 2024, 17:20 ET Drug Discovery Informatics Market size is set to grow by USD 7.28 billion from 2024-2028, Increasing R and D investments by pharmaceutical and biopharmaceutical companies boost the market, Technavio
hardware and specialized expertise are fueling technological advancements in areas like target discovery sequencing and bioinformatics solutions. The biotechnology industry is also investing in AI and computational drug discovery to streamline workflows and accelerate the development of new medications for
More news about: Technavio
Jul 30, 2024, 17:17 ET Gel Documentation Systems Market size is set to grow by USD 52.21 million from 2023-2027, Increase in use of molecular biology techniques in clinical practice boost the market, Technavio
documentation systems have gained significant traction in various industries, including hospitals, diagnostic laboratories, pharmaceutical and biotechnology corporations. These systems are essential for imaging and recording results from agarose and acrylamide gels used in molecular biology. They find
More news about: Technavio
Jul 30, 2024, 17:05 ET Cell Culture Market size is set to grow by USD 24.8 billion from 2024-2028, Increase in infectious diseases to boost the market growth, Technavio
production are major segments. Biotechnology companies and diagnostic laboratories are major players. Mergers and collaborations, such as between Captivate Bio and Merck, are driving innovation in areas like viral vaccines, biopharmaceutical development, pharmaceuticals, biotechnology, testing kits, cell culture
More news about: Technavio
Jul 30, 2024, 17:00 ET New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer's Disease Patients Presented at The Alzheimer's Association International Conference (AAIC) 2024
global). 5. About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients' lives and to create value for shareholders and our communities.
More news about: Eisai Co., Ltd.
Jul 30, 2024, 16:05 ET Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024
July 30, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call and live webcast on Tuesday, August 6, 2024,
More news about: Heron Therapeutics, Inc.
Jul 30, 2024, 14:55 ET Clinical Trial Management System (CTMS) Market size is set to grow by USD 1.86 billion from 2024-2028, Increasing healthcare expenditure to boost the market growth, Technavio
Deployment (On-premise and Cloud), End-user (Pharmaceutical and biotechnology companies, CROs, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW))
More news about: Technavio
Jul 30, 2024, 14:30 ET Near-Infrared (NIR) Spectroscopy Market size is set to grow by USD 698.9 million from 2024-2028, Rising food safety concerns boost the market, Technavio
the chemical composition of various materials. This technology finds applications in diverse industries, including Biotechnology, Agriculture, Healthcare, and Chemicals. In Biotechnology, NIR Spectroscopy is used for insect detection, crime detection in forensic labs, and pharmaceutical production for
More news about: Technavio
Jul 30, 2024, 14:00 ET AuraVax recognizes the University of Houston for publication on intranasal NanoSTING, a broad-spectrum host-directed therapeutic for respiratory viruses
viral etiology and appears unaffected by mutation escape." About AuraVaxAuraVax Therapeutics, Inc. (AuraVax) is a privately held biotechnology company commercializing the NanoSTING platform for the treatment and prevention of multiple respiratory infections. Intranasal NanoSTING is a broad-acting,
More news about: AuraVax Therapeutics Inc.
Jul 30, 2024, 10:01 ET Nocturia Market to Reach US$ 8.5 Billion by 2034, Fueled by the Integration of Wearable Technology and Mobile Health Apps | Transparency Market Research, Inc.
Competitive Landscape The competitive landscape of the nocturia market is characterized by intense rivalry among pharmaceutical giants, biotechnology firms, and medical device companies. Key players like Pfizer, Ferring Pharmaceuticals, and Allergan are investing heavily in R&D to develop
More news about: Transparency Market Research
Jul 30, 2024, 10:00 ET ADLM announces 2024 Top Corporate Supporter Award recipients and thanks them for their vital backing
personally deliver the awards to representatives from each of the following organizations: AbbottAESKU.GROUP GmbHAnbio BiotechnologyBeckman Coulter, Inc.bioMerieuxBio-Rad LaboratoriesCo-Diagnostics, Inc. (Co-Dx)Diagnostics
More news about: Association for Diagnostics & Laboratory Medicine (ADLM)